Novo Nordisk fellowship program
Aug 11, 2014
Novo Nordisk fellowship program
Novo Nordisk at a glanceIntroduction to the company
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership within:• diabetes care• insulin• injection devices
Thanks to dedicated research into proteins, Novo Nordisk also holds leading positions within:• haemostasis management• growth hormone therapy• hormone replacement therapy
Novo Nordisk Worldwide: > 33,000 employees
Production sites
R&D facilities Clinical development centres
Affiliates Representative offices
Regional and business area offices
SeattleBeijing
Denmark
Bangalore
Princeton
R&D locations• Copenhagen, Denmark• Beijing, China• Seattle, WA, USA• Princeton, NJ, USA• Bangalore, India
Clinical Development centres• Zürich, Switzerland• Beijing, China• Princeton, NJ, USA• Tokyo, Japan
>3800 staff today, 5000 staff in 2020Global R&D
The ability to attract talent in Denmark is key to us
81 3898 154
194
27
R&D 4354
Employees in R&D 01-Mar-2013
Additional Novo Nordisk R&D facts
• > DKK 10 billion R&D investment
• Ranked 4th out of 20 international pharmaceutical and biotech companies listed as best employers by Science Magazine
• 778 scientific publication in 2010-11 (2010 h-index: 26)
• 25 PhD and 6 post docs supported through the LIFEPHARM PhD school at University of Copenhagen focussing on pharmacology.
• ~ 100 PhD/PostDoc science students from Europe, North America and Asia
• Top rating in Dow Jones Sustainability Index for the last ten years
8Industry talent requirements and challenges
We rely on excellent talent within all our competency areas to sustain growth
E.coliYeast
Mammalian cellsPrefilled pens
Durable pens
Oral deliveryLiquid delivery
Sustained release
Subc. delivery
Amino acid substitutionAcylation Medical insight
Trial designExecution
Therapy area expertiseModification
Our core beliefs
9Industry talent requirements and challenges
INNOVATION&
GROWTH
Talents
DiversityPerformance
Fellowship Programmes
Talent Attraction
Support of Education System
Long termRelations
Knowledge Transfer
STAR PostDoc Fellows 2013Active and completed 1998 – 30 June 2013
Burnham Institut Medical Research
Clinical Medical Regulatory OfficesR&D locations
Berkley
McGill University
Loyola
Consiglio Nazionale delle Ricerche
Chapel Hill University Princeton
San Francisco University
Sigma Aldrich (SAFC)
Stanford University
Toronto University
Washington University
Vrije University
Harvard
Dublin University
Geneva University
Institute for Biomedicine and Health Science
Justus-Liebig University
Karolinska Institutet
Kings College
Linköping University
Lund University
Manchester University
Martin Luther University
Nottingham University
Santiago de Compostela University
Uppsala University
The Hebrew University-Hadassah
Setsunan University, Osaka, Japan
Tokyo University
Fudan University
Novo Nordisk STAR fellowsProfessional Qualifications
• Strong competences from active research environments
• International experience and networks
• Good publications (and PhD thesis) and/or patent applications
• Skills in new technologies
• High personal ambitions
STAR fellowship postgraduate training 2013
STAR Symposium activities
LIFEPHARMThe Novo Nordisk–LIFE In Vivo Pharmacology CentrePublic – Private – PartnershipEstablished 1/9/2010
Aim•Reinforcement of section of pharmacology and toxicology @ LIFE•Continued output of PhD candidates with ’in vivo’ expertise•Ensure the continuation of the In Vivo PhD Program
Funding •9.1 M Euro 2010-2015
• 6 mill Euros from Novo Nordisk A/S• 3.1 mill Euros from LIFE
Resources•24 PhD scholarships•5 Postdoctoral fellowships (2 years each)•Professorship in clinical pharmacology & toxicology
Framework for an InnoLIFE PhD programme07/04/23
• Novo Science Ambassadors• Novo Nordisk and Novozymes have established a team of young Novo
Scholarship recipients in order to stimulate the interest for natural and medical science in the schools.
• The ambassadors’ lectures are free and can be booked at www.formidling.dk
Novo Science Ambasadors
17Presentation title Date
Recently: Elite Post Doc programme with Oxford University
• A recruitment platform for international top talents within diabetes research
• An international platform for branding NN as a top-science employer
• A platform for on-campus recruitment activities
• A platform for expanding scientific collaboration between NN and UO
• 3-year fellowships fully funded by Novo Nordisk
Objectives Scope
18November 2013
Recently: Elite Post Doc programme with Stanford University
• A recruitment platform for international top talents within immunology research
• An international platform for branding NN as a top-science employer
• A platform for on-campus recruitment activities
• A platform for expanding scientific collaboration between NN and Stanford
• 2 to 3-year fellowships fully funded by Novo Nordisk
Objectives Scope
19November 2013
Institute for Immunity,Transplantion and Infection
Slide no 20 • •
Evaluation of Early innovation/research
New metrics for evaluation of the innovation outcome such as:
• networks created, • access to novel technology & implementation • access to important know-how & implementation
on top of the classical metrics such as: • publications, • patent applications filed, • science citations etc.
Novo Nordisk R&D career paths
• To clarify development opportunities
• To specify qualifiers for different job
types and levels
More information at novonordisk.com/careers